Skip to content
Recall Observatory FDA recall evidence

Drug product

AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.

D-1875-2019

August 28, 2019

Class II

Product summary

Firm
AVKARE Inc.
Event
Event 83700
Status
Terminated
Classification
Class II
Quantity
5953 bottles
Official record key
drug-enforcement:D-1875-2019

Official wording

Reason: Failed Stability Specifications.

Code information: Lot #s: 067180011A; 067180012A, Exp. 04/2021; 06718027B1 Exp. 09/2021

Distribution pattern: Nationwide in the U.S.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Stability Specifications